The Illumina-backed microbial technology producer will list on the Nasdaq Capital Market through the reverse takeover transaction.
MIT spinout Ginkgo Bioworks will go public through a reverse merger with Soaring Eagle Acquisition Corp to list on the Nasdaq Capital Market.
Kakao has agreed to acquire portfolio companies Tapas, for $510m, and Radish, for $440m, as it looks to strengthen its recently merged entertainment subsidiary.
The SAIC, Wanxiang, Full Truck Alliance and Quanta Computer-backed autonomous trucking technology developer will list on the Nasdaq Capital Market through the deal.
The LTL shipping network operator is reportedly targeting $500m in the listing, which would enable corporates Ping An and Yili to exit.
The GV, Louis Dreyfus Company and Emart-backed food development platform creator is pursuing a reverse takeover at a $1.35bn valuation.
AbbVie subsidiary Allergan Aesthetics has agreed to acquire Soliton, which is commercialising a cellulite treatment based on research at University of Texas.
SoftBank vehicle SB Energy and BASF contributed to a $250m PIPE financing that will support the merger with the Nasdaq-listed Acon S2 Acquisition Corp.
The genetic sequencing technology developer has filed to raise up to $100m, having secured nearly $150m from investors including Legend Capital in the past two years.
Cambridge’s gene therapy developer had set terms for an offering set to raise between $135m and $149m on the Nasdaq Global Select Market.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
